
Alnylam Pharmaceuticals, Inc.
USD271.37
-1.30 (-0.48%)
CEO
Yvonne L. Greenstreet
IPO Date
2004-06-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$272.50
Prev. Close
$272.67
Day Low
$270.01
Day High
$278.30
52W Low
$266.27
52W High
$495.55
Market Cap
$36.23B
Volume
0.95M
| 10 Jul 2026 |
| Morgan Stanley |
| Equal Weight |
| Equal Weight |
| maintain |
| 29 Jun 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 4 Jun 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 5 May 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 1 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 1 May 2026 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 13 Apr 2026 | Truist Securities | Buy | Buy | maintain |